These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16949681)

  • 1. Parameters of inhibition of HIV-1 infection by small anionic microbicides.
    Vzorov AN; Bozja J; Dixon DW; Marzilli LG; Compans RW
    Antiviral Res; 2007 Jan; 73(1):60-8. PubMed ID: 16949681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of HIV-1 infection by phthalocyanines.
    Vzorov AN; Marzilli LG; Compans RW; Dixon DW
    Antiviral Res; 2003 Jul; 59(2):99-109. PubMed ID: 12895693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of infection and transmission of HIV-1 and lack of significant impact on the vaginal commensal lactobacilli by carbohydrate-binding agents.
    Petrova MI; Mathys L; Lebeer S; Noppen S; Van Damme EJ; Tanaka H; Igarashi Y; Vaneechoutte M; Vanderleyden J; Balzarini J
    J Antimicrob Chemother; 2013 Sep; 68(9):2026-37. PubMed ID: 23640125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfonated naphthyl porphyrins as agents against HIV-1.
    Dixon DW; Gill AF; Giribabu L; Vzorov AN; Alam AB; Compans RW
    J Inorg Biochem; 2005 Mar; 99(3):813-21. PubMed ID: 15708803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of human immunodeficiency virus type 1 by porphyrins.
    Vzorov AN; Dixon DW; Trommel JS; Marzilli LG; Compans RW
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3917-25. PubMed ID: 12435696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R; Decroly E; Kieny MP; Fenouillet E
    Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti human immunodeficiency virus-1 (HIV-1) agents 3. synthesis and in vitro anti-HIV-1 activity of some N-arylsulfonylindoles.
    Fan LL; Liu WQ; Xu H; Yang LM; Lv M; Zheng YT
    Chem Pharm Bull (Tokyo); 2009 Aug; 57(8):797-800. PubMed ID: 19652402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides.
    Van Herrewege Y; Morellato L; Descours A; Aerts L; Michiels J; Heyndrickx L; Martin L; Vanham G
    J Antimicrob Chemother; 2008 Apr; 61(4):818-26. PubMed ID: 18270220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Virtual screening of small molecular HIV-1 entry inhibitor NC-2 targeting gp120 and its action mechanism].
    Duan H; Wang Y; Song D; Chen Z; Qiu J; Lu L; Jiang S; Liu S; Tan S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):826-31. PubMed ID: 23803191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new potential approach to block HIV-1 replication via protein-protein interaction and strand-transfer inhibition.
    Ferro S; De Luca L; Lo Surdo G; Morreale F; Christ F; Debyser Z; Gitto R; Chimirri A
    Bioorg Med Chem; 2014 Apr; 22(7):2269-79. PubMed ID: 24618511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide.
    Ragno R; Coluccia A; La Regina G; De Martino G; Piscitelli F; Lavecchia A; Novellino E; Bergamini A; Ciaprini C; Sinistro A; Maga G; Crespan E; Artico M; Silvestri R
    J Med Chem; 2006 Jun; 49(11):3172-84. PubMed ID: 16722636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding.
    Uttekar MM; Das T; Pawar RS; Bhandari B; Menon V; Nutan ; Gupta SK; Bhat SV
    Eur J Med Chem; 2012 Oct; 56():368-74. PubMed ID: 22858223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of polyanion-resistance on HIV-1 infection.
    Bobardt MD; Armand-Ugón M; Clotet I; Zhang Z; David G; Este JA; Gallay PA
    Virology; 2004 Aug; 325(2):389-98. PubMed ID: 15246277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV-inhibiting activity of polyanion matrices and related substances containing adamantane and norbornene pharmacophores].
    Timofeev DI; Perminova NG; Serbin AV; Kiseleva IaIu; Nekliudov VV; Vatolin GIu; Kas'ian LI; Grebinik TS; Timofeev IV
    Antibiot Khimioter; 2003; 48(5):33-41. PubMed ID: 12968467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
    Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
    J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains.
    Wang C; Shi W; Cai L; Lu L; Yu F; Wang Q; Jiang X; Xu X; Wang K; Xu L; Jiang S; Liu K
    J Antimicrob Chemother; 2014 Jun; 69(6):1537-45. PubMed ID: 24500189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes.
    Pollicita M; Schols D; Aquaro S; Peumans WJ; Van Damme EJ; Perno CF; Balzarini J
    Virology; 2008 Jan; 370(2):382-91. PubMed ID: 17928023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal human defensins 5 and 6 antagonize the anti-HIV activity of candidate polyanion microbicides.
    Ding J; Rapista A; Teleshova N; Lu W; Klotman ME; Chang TL
    J Innate Immun; 2011; 3(2):208-12. PubMed ID: 21160168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides.
    Van Herrewege Y; Michiels J; Waeytens A; De Boeck G; Salden E; Heyndrickx L; van den Mooter G; de Béthune MP; Andries K; Lewi P; Praet M; Vanham G
    Antiviral Res; 2007 May; 74(2):111-24. PubMed ID: 17097156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ; Uckun FM
    Mol Hum Reprod; 2005 Oct; 11(10):767-77. PubMed ID: 16254003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.